In fact, TS activity has been associated with response to 5-FU in a number of human cancers, and patients with low TS levels were more likely to respond compared to patients with high TS levels (Kornmann et al, 1997; Allegra et al, 2003). This evidence concerns the gene TYMS and cancer.